Premium
The In‐vitro Antifungal Spectrum of Itraconazole
Author(s) -
Cutsem J.
Publication year - 1989
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/j.1439-0507.1989.tb02290.x
Subject(s) - itraconazole , microbiology and biotechnology , microsporum canis , biology , aspergillus fumigatus , dimorphic fungus , cryptococcus , candida albicans , trichophyton , cryptococcus neoformans , sporothrix , aspergillus , candida parapsilosis , candida tropicalis , yeast , antifungal , sporotrichosis , immunology , genetics
Summary: The activity of itraconazole on 6113 fungal strains belonging to 252 species was evaluated in fluid media. The test medium was brain heart infusion broth for all fungi, except for Pityrosporum ovale , for which it was Dixon broth. Most of the human and animal pathogens and a large number of saprophytes were highly sensitive: dermatophytes, Candida, Cryptococcus, Torulopsk, Pityrosporum, Aspergillus, Penicillium, Sporothrix , dimorphic fungi, phaeohyphomycetes, agents of eufungal mycetoma, Entomophtorales and various others. The majority of Fusarizm species and the Zygomycetes were poorly sensitive. Itraconazoie was not only fungistatic at low concentrations, but also fungicidal for the tested organisms, such as Microsporum canis, Trichophyton mentagrophytes, Candida albicans, C. tropicalis, Aspergillus fumigatus, P. ovale and Cryptococcus neofor‐mans with or without replenishment. Itraconazole was able to block the morpho‐genetic transformation of C. albicam from the yeast phase into the (pseudo)‐mycelium phase.